XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Operations - USD ($)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Net revenues $ 8,497,701 $ 9,224,638
Costs and expenses:    
Cost of products sold 1,575,542 1,250,264
Selling and marketing 4,154,588 4,277,318
Research and development 1,158,253 1,499,670
General and administrative 2,367,907 2,498,993
Amortization 1,110,661 1,230,071
Total costs and expenses 10,366,951 10,756,316
Operating loss (1,869,250) (1,531,678)
Interest income 96,746 50,190
Other income 0 1,847,065
Interest expense (118,526) (186,353)
Income (loss) before income taxes (1,891,030) 179,224
Income tax expense (11,442) (6,938)
Net income (loss) (1,902,472) 172,286
Net (income) loss at subsidiary attributable to noncontrolling interests (43,791) 19,898
Net income (loss) attributable to common shareholders $ (1,946,263) $ 192,184
Earnings (loss) per share attributable to common shareholders    
Basic (in USD per share) $ (0.14) $ 0.01
Diluted (in USD per share) $ (0.14) $ 0.01
Weighted-average shares outstanding    
Basic (in shares) 14,098,022 14,359,322
Diluted (in shares) 14,098,022 14,587,843